ACH-126445

N/A

Report date: 2023/04/23 15:14:12

Base Information

Drug NameACH-126445
Drug Alias NameL-OddU
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsLymphoproliferative DisordersNasopharyngeal NeoplasmsInfectious Mononucleosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAchillion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAchillion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLymphoproliferative DisordersNasopharyngeal NeoplasmsInfectious Mononucleosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A